Strensiq (asfotase alfa); Alexion; For the treatment of hypophosphatasia, Approved October 2015
Otezla (apremilast); Celgene; For the treatment of adults with active psoriatic arthritis, Approved March 2014
Xgeva (denosumab); Amgen; For the treatment of giant cell tumor of bone, Approved June 2013
Rayos (prednisone) delayed-release tablets; Horizon Pharma; For the treatment of certain inflammatory diseases, including arthritis, COPD, asthma and psoriatic conditions, Approved July of 2012
Prolia (denosumab); Amgen; For the treatment of osteoporosis and bone loss in men and women, Approved June 2010
Amrix (cyclobenzaprine hydrochloride extended release); Cephalon; For the treatment of muscle spasm associated with acute, painful musculoskeletal conditions, Approved February 200